GB1597345A - Diagnostic immunochemical test materials and procedure - Google Patents
Diagnostic immunochemical test materials and procedure Download PDFInfo
- Publication number
- GB1597345A GB1597345A GB5199077A GB5199077A GB1597345A GB 1597345 A GB1597345 A GB 1597345A GB 5199077 A GB5199077 A GB 5199077A GB 5199077 A GB5199077 A GB 5199077A GB 1597345 A GB1597345 A GB 1597345A
- Authority
- GB
- United Kingdom
- Prior art keywords
- component
- antibody
- membrane
- antigen
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 65
- 238000012360 testing method Methods 0.000 title claims description 42
- 230000000984 immunochemical effect Effects 0.000 title claims description 31
- 239000000463 material Substances 0.000 title description 12
- 239000012528 membrane Substances 0.000 claims description 76
- 239000000427 antigen Substances 0.000 claims description 75
- 102000036639 antigens Human genes 0.000 claims description 75
- 108091007433 antigens Proteins 0.000 claims description 75
- 229940088598 enzyme Drugs 0.000 claims description 38
- 102000004169 proteins and genes Human genes 0.000 claims description 37
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 102000004190 Enzymes Human genes 0.000 claims description 35
- 108090000790 Enzymes Proteins 0.000 claims description 35
- 238000006243 chemical reaction Methods 0.000 claims description 32
- 239000012530 fluid Substances 0.000 claims description 30
- 239000011148 porous material Substances 0.000 claims description 29
- 210000002966 serum Anatomy 0.000 claims description 29
- 239000012982 microporous membrane Substances 0.000 claims description 27
- 241000223996 Toxoplasma Species 0.000 claims description 20
- 230000007935 neutral effect Effects 0.000 claims description 17
- 239000000758 substrate Substances 0.000 claims description 16
- 102000003992 Peroxidases Human genes 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 15
- 229920002494 Zein Polymers 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- 229940093612 zein Drugs 0.000 claims description 13
- 239000005019 zein Substances 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- 241000223997 Toxoplasma gondii Species 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 6
- 239000012894 fetal calf serum Substances 0.000 claims description 6
- 241000283690 Bos taurus Species 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 108010074605 gamma-Globulins Proteins 0.000 claims description 5
- CMUHFUGDYMFHEI-QMMMGPOBSA-N 4-amino-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N)C=C1 CMUHFUGDYMFHEI-QMMMGPOBSA-N 0.000 claims description 4
- 102000008946 Fibrinogen Human genes 0.000 claims description 4
- 108010049003 Fibrinogen Proteins 0.000 claims description 4
- 108010068370 Glutens Proteins 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 102000011782 Keratins Human genes 0.000 claims description 4
- 108010076876 Keratins Proteins 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000337 buffer salt Substances 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229940012952 fibrinogen Drugs 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 108010039177 polyphenylalanine Proteins 0.000 claims description 4
- 108010011723 polytryptophan Proteins 0.000 claims description 4
- 108010033949 polytyrosine Proteins 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 108010015776 Glucose oxidase Proteins 0.000 claims description 3
- 239000004366 Glucose oxidase Substances 0.000 claims description 3
- 230000006978 adaptation Effects 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229940116332 glucose oxidase Drugs 0.000 claims description 3
- 235000019420 glucose oxidase Nutrition 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 claims description 2
- 241000700721 Hepatitis B virus Species 0.000 claims description 2
- 108010055615 Zein Proteins 0.000 claims description 2
- 229960005188 collagen Drugs 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 239000013642 negative control Substances 0.000 claims description 2
- -1 polyisoleucin Proteins 0.000 claims description 2
- 108010057904 polyisoleucine Proteins 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 230000009257 reactivity Effects 0.000 claims description 2
- 229960000212 aminophenazone Drugs 0.000 claims 1
- 239000013641 positive control Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
- 239000000306 component Substances 0.000 description 60
- 238000003556 assay Methods 0.000 description 21
- 238000011534 incubation Methods 0.000 description 18
- 230000027455 binding Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 14
- 230000009871 nonspecific binding Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical group CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
- 206010057179 Toxoplasma infections Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000035931 haemagglutination Effects 0.000 description 4
- 230000003100 immobilizing effect Effects 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- DPISVYSMNIFXGB-UHFFFAOYSA-N 2-(9h-carbazol-3-yl)ethanamine Chemical group C1=CC=C2C3=CC(CCN)=CC=C3NC2=C1 DPISVYSMNIFXGB-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 201000005485 Toxoplasmosis Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 201000007045 Congenital toxoplasmosis Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000006941 Laboratory Infection Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 101000882917 Penaeus paulensis Hemolymph clottable protein Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000012817 gel-diffusion technique Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-M periodate Chemical compound [O-]I(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-M 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 244000000040 protozoan parasite Species 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012205 qualitative assay Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75109976A | 1976-12-16 | 1976-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1597345A true GB1597345A (en) | 1981-09-03 |
Family
ID=25020478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5199077A Expired GB1597345A (en) | 1976-12-16 | 1977-12-14 | Diagnostic immunochemical test materials and procedure |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA1104927A (enrdf_load_stackoverflow) |
| DE (1) | DE2755689A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2374646A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1597345A (enrdf_load_stackoverflow) |
| IT (1) | IT1089403B (enrdf_load_stackoverflow) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2125963A (en) * | 1982-06-18 | 1984-03-14 | Mochida Pharm Co Ltd | Carriers for immunochemical measurement and measuring reagents utilizing said carriers |
| WO1986002160A1 (en) * | 1984-09-26 | 1986-04-10 | Jan Peter Andersson | Device and method for trapping and analyzing particles |
| US4822732A (en) * | 1984-01-24 | 1989-04-18 | Sandstroem Gunnar | Method of concentrating and detecting biomolecules and cells |
| US5486452A (en) * | 1981-04-29 | 1996-01-23 | Ciba-Geigy Corporation | Devices and kits for immunological analysis |
| EP1373467A4 (en) * | 2001-03-28 | 2007-06-06 | Genetech Biotechnology Shangai | DEVICE AND METHOD FOR DETECTING MULTIPLE ANALYZES |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2430013A1 (fr) * | 1978-06-27 | 1980-01-25 | Sebia Sa | Systeme physico-biochimique pour la detection des substances, a activite antigenique |
| DE3206729A1 (de) * | 1982-02-25 | 1983-09-01 | Behringwerke Ag, 3550 Marburg | Immunologisches agglutinationsverfahren |
| US4526690A (en) * | 1983-02-04 | 1985-07-02 | Millipore Corporation | Apparatus for nucleic acid quantification |
| FR2569478B1 (fr) * | 1984-08-23 | 1987-01-09 | Guerin Bernard | Bandelette d'analyse immunologique et procede pour sa fabrication |
| US4960692A (en) * | 1986-03-18 | 1990-10-02 | Fisher Scientific Company | Assay employing binding pair members on particles and on a filter or membrane |
| WO1989000446A1 (en) * | 1987-07-16 | 1989-01-26 | E.I. Du Pont De Nemours And Company | Affinity separating using immobilized flocculating reagents |
-
1977
- 1977-12-14 DE DE19772755689 patent/DE2755689A1/de not_active Ceased
- 1977-12-14 GB GB5199077A patent/GB1597345A/en not_active Expired
- 1977-12-16 IT IT3083277A patent/IT1089403B/it active
- 1977-12-16 CA CA293,253A patent/CA1104927A/en not_active Expired
- 1977-12-16 FR FR7738120A patent/FR2374646A1/fr active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486452A (en) * | 1981-04-29 | 1996-01-23 | Ciba-Geigy Corporation | Devices and kits for immunological analysis |
| GB2125963A (en) * | 1982-06-18 | 1984-03-14 | Mochida Pharm Co Ltd | Carriers for immunochemical measurement and measuring reagents utilizing said carriers |
| US4822732A (en) * | 1984-01-24 | 1989-04-18 | Sandstroem Gunnar | Method of concentrating and detecting biomolecules and cells |
| WO1986002160A1 (en) * | 1984-09-26 | 1986-04-10 | Jan Peter Andersson | Device and method for trapping and analyzing particles |
| EP1373467A4 (en) * | 2001-03-28 | 2007-06-06 | Genetech Biotechnology Shangai | DEVICE AND METHOD FOR DETECTING MULTIPLE ANALYZES |
Also Published As
| Publication number | Publication date |
|---|---|
| IT1089403B (it) | 1985-06-18 |
| CA1104927A (en) | 1981-07-14 |
| DE2755689A1 (de) | 1978-06-22 |
| FR2374646B1 (enrdf_load_stackoverflow) | 1984-03-16 |
| FR2374646A1 (fr) | 1978-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4407943A (en) | Immobilized antibody or antigen for immunoassay | |
| CA1149277A (en) | Process for determining immuno-complexes | |
| US4200690A (en) | Immunoassay with membrane immobilized antibody | |
| US5695928A (en) | Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction | |
| EP0296398B1 (en) | Immunoassay method for detecting antibodies to antigens | |
| US4508829A (en) | Method and kit for pregnancy detection | |
| US5169757A (en) | Antibodies or antigens bound to a macroporous hydrophobic synthetic polymer cloth for immunological techniques | |
| US5200312A (en) | Membrane based dot immunoassay and method of use | |
| HK1008442B (en) | Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction | |
| US5155022A (en) | Assay for lyme disease | |
| DK174032B1 (da) | Sæt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler | |
| CA2105515A1 (en) | Visual immunoassay method for the detection of ligands, based on the use of opaque plastic supports | |
| GB1597345A (en) | Diagnostic immunochemical test materials and procedure | |
| US5122452A (en) | Enzyme immunoassay with a macroporous hydrophobic synthetic polymer cloth containing an immobilized antibody or antigen | |
| JP2732124B2 (ja) | 固相免疫検定用品及び該品を利用した検定法 | |
| IE901081L (en) | Enzymatic assay kit and method applicable to whole cells | |
| AU625344B2 (en) | Chlamydia half-sandwich immunoassay | |
| EP0152254A2 (en) | Chromogenic support immunoassay utilizing labeled complement components | |
| EP0503517A1 (en) | Improved assay for lyme disease | |
| CA2019048C (en) | Cloth enzyme immunoassay | |
| JPH05209879A (ja) | ヘモグロビンの免疫学的検出方法 | |
| RU2196335C1 (ru) | Способ определения гетерогенных антигенов, сходных для микроорганизмов и органов человека и животного | |
| RU2056057C1 (ru) | Способ получения иммобилизованного иммуноглобулина на твердой фазе | |
| CA1291949C (en) | Cloth enzyme immunoassay | |
| Plapp et al. | The dot blot direct antiglobulin test |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |